These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 381522)

  • 1. Immunity to the T1699 murine mammary tumor. I. Thymic influence and long-term effect of irradiation on the humoral response.
    Parthenais E; Haskill S
    J Immunol; 1979 Sep; 123(3):1329-33. PubMed ID: 381522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune response to inactivated syngeneic mammary adenocarcinoma cells. I. Role and regulation of antibody synthesis in DBA/2 mice.
    DeLustro F; Haskill JS
    J Natl Cancer Inst; 1980 Jan; 64(1):125-30. PubMed ID: 6928037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The antibody response to the T1699 murine adenocarcinoma: antibody class and subclass heterogeneity detected in serum and in situ.
    Haskill JS; Radov LA; Fett JW; Parthenais E
    J Immunol; 1977 Sep; 119(3):1000-5. PubMed ID: 19530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunologic factors influencing the intra-tumor localization of ADCC effector cells.
    Haskill S; Parthenais E
    J Immunol; 1978 Jun; 120(6):1813-7. PubMed ID: 659877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunity to the T1699 murine mammary tumor. II. Thymic influence on the in situ inflammatory response, metastatic growth and invasiveness.
    Parthenais E; Haskill S
    J Immunol; 1979 Sep; 123(3):1334-8. PubMed ID: 313951
    [No Abstract]   [Full Text] [Related]  

  • 6. Thymic involution and thymocyte phenotypic alterations induced by murine mammary adenocarcinomas.
    Fu Y; Paul RD; Wang Y; Lopez DM
    J Immunol; 1989 Dec; 143(12):4300-7. PubMed ID: 2592775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunologic responses to a murine mammary adenocarcinoma: in vitro production of specific killer cells is dependent on active T lymphocytes.
    Yamamura Y
    J Immunol; 1978 Jan; 120(1):286-92. PubMed ID: 75226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Splenic alterations during mammary tumorigenesis: diverse effects on different immune parameters.
    Paul RD; Ghaffar A; Sigel MM; Charyulu V; Lopez DM
    Anticancer Res; 1981; 1(2):63-9. PubMed ID: 6214206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Possible evidence for antibody-dependent macrophage-mediated cytotoxicity directed against murine adenocarcinoma cells in vivo.
    Haskill JS; Fett JW
    J Immunol; 1976 Nov; 117(5 Pt.2):1992-8. PubMed ID: 993593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody-mediated suppression of grafted lymphoma. III. Evaluation of the role of thymic function, non-thymus-derived lymphocytes, macrophages, platelets, and polymorphonuclear leukocytes in syngeneic and allogeneic hosts.
    Shin HS; Hayden M; Langley S; Kaliss N; Smith MR
    J Immunol; 1975 Apr; 114(4):1255-63. PubMed ID: 1078832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NK cells from mammary tumor bearing mice do not exert natural killer activity but function as antibody dependent cellular cytotoxicity effectors.
    Rivera LM; Lopez DM
    Anticancer Res; 1993; 13(1):177-84. PubMed ID: 8476211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expansion of immunoregulatory macrophages by granulocyte-macrophage colony-stimulating factor derived from a murine mammary tumor.
    Fu YX; Watson G; Jimenez JJ; Wang Y; Lopez DM
    Cancer Res; 1990 Jan; 50(2):227-34. PubMed ID: 2136804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rejection of mammary adenocarcinoma cell tumors in DBA/2 mice immunocompromised by thymectomy and treatment with antithymocyte serum.
    Likhite VV
    J Immunol; 1975 Jun; 114(6):1736-42. PubMed ID: 1092759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Murine tumor cell lysis by antibody-dependent macrophage-mediated cytotoxicity using syngeneic monoclonal antibodies.
    Kawase I; Komuta K; Ogura T; Fujiwara H; Hamaoka T; Kishimoto S
    Cancer Res; 1985 Apr; 45(4):1663-8. PubMed ID: 3978634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T cell subsets in the immune rejection of murine heterotopic corneal allografts.
    Matoba AY; Peeler JS; Niederkorn JY
    Invest Ophthalmol Vis Sci; 1986 Aug; 27(8):1244-54. PubMed ID: 2942516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody-dependent cell-mediated cytotoxicity. Comparative ability of murine Peyer's patch and spleen cells to lyse lipopolysaccharide-coated and uncoated erythrocytes.
    Kagnoff MF; Campbell S
    Gastroenterology; 1976 Mar; 70(3):341-6. PubMed ID: 1082425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Importance of Lyt-2+ T-cells in the resistance of melphalan-cured MOPC-315 tumor bearers to a challenge with MOPC-315 tumor cells.
    Barker E; Mokyr MB
    Cancer Res; 1988 Sep; 48(17):4834-42. PubMed ID: 3261626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrophage-mediated, antibody-dependent destruction of tumor cells in DBA/2 mice: in vitro identification of an in situ mechanism.
    Key M; Haskill S
    J Natl Cancer Inst; 1981 Jan; 66(1):103-10. PubMed ID: 7005500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of concanavalin A on the in vitro responses of mouse spleen cells to T-dependent and T-independent antigens.
    Jacobs DM
    J Immunol; 1975 Jan; 114(1 Pt 2):365-70. PubMed ID: 1090654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type II collagen-induced murine arthritis. I. Induction and perpetuation of arthritis require synergy between humoral and cell-mediated immunity.
    Seki N; Sudo Y; Yoshioka T; Sugihara S; Fujitsu T; Sakuma S; Ogawa T; Hamaoka T; Senoh H; Fujiwara H
    J Immunol; 1988 Mar; 140(5):1477-84. PubMed ID: 3257978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.